Development of a patient-reported outcome (PRO) instrument to facilitate timing of end-of-life (EOL) discussions in patients with advanced cancers
Characterization of early stage Breast Cancer patient management in a practice setting with the 21-Gene Breast Cancer assay
Utilization and clinical impact of genomic profiling for EGFR and ALK in non-squamous non-small cell lung cancer (NSCLC) in the community setting
Prevalence of clinically meaningful prognostic variability in cancer: An analysis using a new taxonomy system
